Literature DB >> 19948721

S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion.

Mohammad Aminur Rahman1, Takeshi Senga, Satoko Ito, Toshinori Hyodo, Hitoki Hasegawa, Michinari Hamaguchi.   

Abstract

Nitric oxide (NO) plays a pivotal role in tumorigenesis, particularly with relation to cancer cell invasion and metastasis. NO can reversibly couple to cysteine thiols to form an S-nitrosothiol, which regulates the enzymatic activities of target proteins. c-Src is a tyrosine kinase that promotes cancer cell invasion and metastasis. Interestingly, c-Src can be activated by NO stimulation. However, mechanisms by which NO stimulates Src kinase activity have not been elucidated. We report here that NO causes S-nitrosylation of c-Src at cysteine 498 (Cys(498)) to stimulate its kinase activity. Cys(498) is conserved among Src family kinases, and Cys(506) of c-Yes, which corresponds to Cys(498) of c-Src, was also important for the NO-mediated activation of c-Yes. Estrogens may work synergistically with NO to induce the proliferation and migration of many kinds of breast cancer cells. For example, beta-estradiol induces the expression of endothelial nitric synthase and production of NO in MCF7 cells. We found that activation of c-Src in MCF7 cells by beta-estradiol stimulation was mediated by the S-nitrosylation of Cys(498). In addition, we report that disruption of E-cadherin junctions and enhancement of cell invasion by beta-estradiol stimulation was mediated by NO-dependent activation of c-Src. These results identify a novel signaling pathway that links NO and Src family kinases to cancer cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948721      PMCID: PMC2823522          DOI: 10.1074/jbc.M109.059782

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7 - estrogen has an influence on e-NOS, but not on i-NOS.

Authors:  Sibylle Loibl; Jutta Bratengeier; Vincent Farines; Gunter von Minckwitz; Birgit Spänkuch; Valérie Schini-Kerth; Françoise Nepveu; Klaus Strebhardt; Manfred Kaufmann
Journal:  Pathol Res Pract       Date:  2005-12-02       Impact factor: 3.250

Review 2.  Src redox regulation: there is more than meets the eye.

Authors:  Paola Chiarugi
Journal:  Mol Cells       Date:  2008-09-05       Impact factor: 5.034

3.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.

Authors:  Tamer T Onder; Piyush B Gupta; Sendurai A Mani; Jing Yang; Eric S Lander; Robert A Weinberg
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

4.  Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.

Authors:  T Senga; K Miyazaki; K Machida; H Iwata; S Matsuda; I Nakashima; M Hamaguchi
Journal:  Oncogene       Date:  2000-01-13       Impact factor: 9.867

5.  Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress.

Authors:  Michael T Forrester; Matthew W Foster; Jonathan S Stamler
Journal:  J Biol Chem       Date:  2007-03-21       Impact factor: 5.157

6.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.

Authors:  S R Jaffrey; H Erdjument-Bromage; C D Ferris; P Tempst; S H Snyder
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

7.  Tumour maintenance is mediated by eNOS.

Authors:  Kian-Huat Lim; Brooke B Ancrile; David F Kashatus; Christopher M Counter
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

8.  The cysteine-cluster motif of c-Yes, Lyn and FAK as a suppressive module for the kinases.

Authors:  Mohammad Aminur Rahman; Takeshi Senga; Myat Lin Oo; Hitoki Hasegawa; Md Helal Uddin Biswas; Naing Naing Mon; Pengyu Huang; Satoko Ito; Tadashi Yamamoto; Michinari Hamaguchi
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

9.  Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation.

Authors:  David J Kemble; Gongqin Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

Review 10.  Biochemistry of nitric oxide and its redox-activated forms.

Authors:  J S Stamler; D J Singel; J Loscalzo
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

View more
  53 in total

1.  Role of ghrelin-induced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2011-04-24       Impact factor: 4.473

Review 2.  Regulation by S-nitrosylation of protein post-translational modification.

Authors:  Douglas T Hess; Jonathan S Stamler
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 3.  The good and bad effects of cysteine S-nitrosylation and tyrosine nitration upon insulin exocytosis: a balancing act.

Authors:  Dean A Wiseman; Debbie C Thurmond
Journal:  Curr Diabetes Rev       Date:  2012-07-01

Review 4.  Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.

Authors:  Elizabeth A Grimm; Andrew G Sikora; Suhendan Ekmekcioglu
Journal:  Clin Cancer Res       Date:  2013-07-18       Impact factor: 12.531

5.  S-nitrosoglutathione reductase in human lung cancer.

Authors:  Nadzeya V Marozkina; Christina Wei; Sean Yemen; Horst Wallrabe; Alykhan S Nagji; Lei Liu; Tatiana Morozkina; David R Jones; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

6.  S-nitrosylation of c-Src via NMDAR-nNOS module promotes c-Src activation and NR2A phosphorylation in cerebral ischemia/reperfusion.

Authors:  Li-Juan Tang; Chong Li; Shu-Qun Hu; Yong-Ping Wu; Yan-Yan Zong; Chang-Cheng Sun; Fa Zhang; Guang-Yi Zhang
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

7.  Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Farnaz R Bakhshi; Mao Mao; Graeme Carnegie; Marcelo G Bonini; David E Schwartz; Alain Borgeat; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2014-06       Impact factor: 7.892

8.  eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.

Authors:  Annarita Di Lorenzo; Michelle I Lin; Takahisa Murata; Shira Landskroner-Eiger; Michael Schleicher; Milankumar Kothiya; Yasuko Iwakiri; Jun Yu; Paul L Huang; William C Sessa
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

Review 9.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.

Authors:  Debashree Basudhar; Veena Somasundaram; Graciele Almeida de Oliveira; Aparna Kesarwala; Julie L Heinecke; Robert Y Cheng; Sharon A Glynn; Stefan Ambs; David A Wink; Lisa A Ridnour
Journal:  Antioxid Redox Signal       Date:  2016-09-07       Impact factor: 8.401

10.  RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dongsheng Wang; Lydia Koenig; Sreenivas Nannapaneni; Zhengjia Chen; Zhibo Wang; Gabriel Sica; Xingming Deng; Zhuo Georgia Chen; Dong M Shin
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.